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Abstract 
 
The current study is aimed at the synthesis and Analgesic evaluation of 
quinazolinone derivatives. The condensation of Methyl-2-amino-5-
bromobenzoate with acetic anhydride yielded the cyclic compound 2-methyl 6-
bromo-1, 3-benzo-oxazine-4-one which further produce 3-Amino-2-Methyl 6-
bromoquinazolin4(3H)-ones via the reaction with hydrazine hydrate. The 
compounds synthesized were unequivocally confirmed by means of 
Chromatography Mass Spectrophotometer and Elemental analysis.  The 
quinazolonones were evaluated pharmacologically for their in-vivo analgesic 
activities by acetic acid induced writhing in mice. The two investigated 
compounds exhibited significant analgesic activity in the range of 74.67 - 
83.80% in compared to control. 
 
Keywords: Analgesic, 3-amino-6-bromo-2-methyl quinazolin-4(3H)-
one, 6-bromo-2-methyl-4H-benzo [d] [1,3]-oxazine-4-one, Nucleophile, 
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Introduction 
 
The synthesis of quinazolinoneheterocycles has become the cornerstone for synthetic chemists 
and gained extensive importance in medical chemistry because of their diverse pharmacological 
activities including anti-mycobacterial (Ammar, 2011), Grover, 2006 and Waisser, 2001), anti-
fungal (Tiwari et al., 2007), antimalarial (Martin, et al., 1964), antihypertensive (Alagarsamy et al., 
2007), Garcin et al., 2000 and Jen, T et al, 1973), antihistaminic (Alagarsamy et al., 2006, Alagarsamy 
et al., 2005a, Alagarsamy et al., 2005b, Alagarsamy et al., 2005c), cardiotonic )Dempy et al., 
1993), anticancer (Abdel-Rahman, 1998, El- Bayouki et al., 2009 and Hour et al., 2000), 
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antiviral (Alagasamy et al., 2004), and thymidylate synthase inhibitory activities 
(Hennequin et al., 1996) and Marshaszsm et al., 1991). 
 
The 2,3-disubstituted  quinazolones have been predicted to possess antiviral and 
antihypertensive activities (Pandey and other 2004). 
 
Benzoxazneheterocylic compounds are potent non-steridalprognesterone receptor 
agoinsts (Zheng et al., 2002), having mang other activities such as anticancer, 
antiangiogenic (LaDS et al., 2008), antidiabetic and hypolipidemic (Madhavan et al., 2006), 
antidepressant (Zhou et al., 2006) and antiplatelet aggregation activities (Pritchard et al., 
2007). 
 
These findings prompted the author to synthesis these quinazolinone derivatives via the 
interaction of the benzoxazinone derivatives with different nitrogen nucleophiles, with 
the aim of obtaining more precise information about the course of the reaction and 
determine the Analgesic properties. 
 
Chemistry 
The introduction of 2-amino substituent is a successful strategy to improve the chemical 
stability of benzoxazinone. Due to the pharmacological activities of 4(3H)-quinazolinone 
derivatives, 2,3-disubstituted derivative of quinazoline-4-one were synthesized via the 
interaction of the benzoxazinone derivative with nitrogen nucleophile with the aim of 
obtaining more precise information about the course of the reaction and some interesting 
pharmaceutical compounds. The reaction of 4, 5-disubstituted derivatives of 
methylanthranilate and acetic anhydride yielded the cyclic compound 7-chloro 2-methyl-
4H-benzo [d][1,3] -oxazin-4-one. The reaction of this compound with hydrazine hydrate 
yielded 3-amino-7-chloro-2-methyl-quinazoline-4(3H)-one. 
 
Materials and methods 
General Experimental Procedure 
All reagents and solvents were purchased from sigma-Aldrich, in Germany. Melting 
points were determined on a kofler hot stage apparatus and were uncorrected. IR spectra 
were recorded on a Buck scientific IR M500 instrument. The 1H and 13C NMR spectra 
were recorded in DMSO-d6 at 400 MHz with HAZ VOLATILE V2. M Chemical shifts Sare 
reported in ppm relative to tetramethylsilane. Gas chromatography mass spectra were 
obtained on a Finingan MAT 44S mass spectrophotometer operating at 70eV.  Elemental; 
analysis agreed favourably with the calculated values Analytical thin layer 
chromatography (TLC) was used to monitor the reactions.  
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Elemental Analysis  
The compositions of the compounds are summarized in Table 1. The C and H contents 
(both theoretically calculated values and actual values) are indicated. 
 
 
General Procedure for the Synthesis of 6-bromo-2-methyl-4H-benzo [d] [1,3]-Oxazin-
4-One, (1). 
This involved the condensation of 0.76g (0.005mol) Methyl 2-amino-5-bromobenzoate  
with 10ml, 1.02g, (0.01mol) acetic anhydride in 30ml ethanol medium. The reaction was 
heated under reflux with stirring using a magnetic stirrer until the reaction mixture 
showed no trace of starting material when the TLC was developed (2 hours).Yield was 
2.01g (96%), mp: 149-151oC. 
 
General Procedure for the Synthesis of 3-amino-6-bromo-2-Methyl-Quinazoline-4(3h)-
One (2). 
Equimolar amounts (1.61g, 0.01mol) of 6-bromo-2-methyl-4H-benzo [d] [1,3]-oxazine-4-
one, and (0.51g, 0.01mol) hydrazine hydrate were heated under reflux in 30ml ethanol 
with stirring using a magnetic stirrer until the reaction mixture showed no trace of  
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starting material when the TLC was developed (3 hours). At the end of the reaction, the 
reaction mixture was concentrated in vacuum under reduced pressure using rotary 
evaporator.  The white precipitate formed was then filtered, washed three times with 
20ml of distilled water [20ml x 3].  The white crystals were dried and recrystallized from 
dimethylformamide (DMF) to give pure 3-amino-6-bromo-2-methyl-quinazolin-4 (3H) –
one.  Yield was 1.50g (95%) mp : 138-140oC 
 
Pharmacologcal Evaluation 
Swiss mice (18-23g) of both sexes were used. The animals were maintained under 
standard diet Sand water. Test compounds were administered orally at dose levels. Ethics 
committee of the Faculty of Pharmacy, University of Benin, Benin City, Nigeria. 
 
Analgesic activity 
The acetic acid induced abdominal constriction method is widely used for the evaluation 
of peripheral antinociceptive activity (Gene et al., 1998). It is very sensitive and able to 
detect antinociceptive effects of compounds at dose levels that may appear inactive in 
other methods like the tail-flick test (collier et al., 1968. Bentley et al., 1981). Local 
perietoneal receptors are postulated to be partly involved in the abdominal constriction 
response (Bentley et al., 1983). The method has been associated with prostanoids in 
general, e.g increased levels of PGE2 and PGE2a in peritoneal fluids (Derarit et al., 1980), 
as well as lipoxygenase products by some researchers (Levini et al., 1984), Dhara et al., 
2000). Indomethaan (10mg/kg) was administered orally as reference drug while 10% 
olive oil was used as negative 
 
Statistical analysis  
All data were expressed as the mean + SEM, the students’t-test was applied to determine 
the significance of the difference between the control group and the test compounds. 
 
Results and discussion  
 
Table 1: Characterization and Physical data of Synthesized Compounds 
Compound No Solvent 
 
Formula M. wt Analysis% Calc/Found 
          C                                H 
1 Ethanol C9H6BrN02 
(240.053) 
 
55.22 
55.21 
 
3.08 
3.07 
2 Ethanol C9H8BrN30 
(254.083) 
 
51. 53 
51. 52 
3.83 
3.82 
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Table 2: 13C-NMR of Synthesized Compounds 
Compound No δ (ppm) Carbon atom number 
 
 
 
 
153.12(C-1),168.18(C-2),120.90(C-3), 128.28 (C-4), 
113.37 (C-5), 133.77 (C-6), 122.10 (C-7), 149.28 (C-
8), 25.10 (C-9) 
 
 
 
 
 
154.53 (C-1), 160.10 (C-2), 120.25 (C-3), 128.07 (C-
4), 133.50 (C-5) 113.53 (C-6), 122.14 (C-7), 148.22 
(C – 8), 22.30 (C- 9). 
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0 
2 
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Table 3: 1H-NMR of Synthesized Compounds 
Compound No δ (ppm) 
 
 
 
 
 
8.23 (s, 1H), 8.14 (s, 1H), 6.40 (s, 1H), 2.50 (s, 3H) 
 
 
 
 
8.21 (2s, 2H), 8.11 (Ar-1H), 7.10 (s, 1H), 5.80 (s, 1H), 
2.40 (s, 3H) 
 
 
Characterization of 6-bromo 2-Methyl-4H-benzo [d][1,3] -Oxazin-4-One.(1). 
1H NMR (400MHz, DMSO) δ 8.23 (s, 1H), 8.14 (s, 1H), 6.40 (s, 1H), 2.50 (s, 3H), 13(NMR 
(400MHz, DMSO) δ 168.18, 153.12, 149.28, 133.77, 128.28, 122.10, 120.90, 113.37, 25.10. IR 
(KBr,cm1) 3135, (NH2), 3018 (CH aromatic), 2951, 2871, 2718 (CH 
aliphatic),1730(C=0),1150 (C-0).Anal. Cal for C9H6BrN02 ; C 55.21; H 3.07. Found: C 55.22, 
H 3.08.  Yield was 2.01g (96%), mp: 149-151oC. 
 
Characterization of3-amino- 6-bromo 2-methyl-quinazoline-4(3H)-one. (2). 
1H NMR (400 MHz, DMSO) δ 8.21 (2s, 2H), 8.11 (Ar-H), 7.10 (s,1H),5.80 (s, 1H), 2.40 (s, 
3H), 13C NMR (400MHz, DMSO) δ 160.10, 154.53, 148.22, 133.50, 128.07, 122.14, 120.25, 
113.53, 22.30, IR (KBr,cm1)3350(NH2),1685 (C=0),1620 (C=N), Anal. Cal. for C9H8BrN30; C 
51. 52, H 3.82; Found, C 51.53, H 3.83.Yield was 1.00g (95%) mp: 98-100oC. 
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Table 4: Effect of the test compounds on acetic acid induced writhing in mice. 
Compound No Does mg/kg 
(p.o) 
Numbers of writhing (per 20 
min) 
% Inhibition 
 
1 20 
40 
36.11 + 0.18 
20.42 + 2.45 
74.67 
77.41 
2 20 
40 
27.56 + 1.16 
16.01 + 0.22 
79.06 
83.80 
    
TWEEN 80 0.2ML 69.00 + 0.12 
 
 
Acetylsalicylic 
acid 
 22.50 + 3.07 67.39 
Indomethacin 10 14.80 + 4.95 78.55 
  Values are meant + S.E.M; P<0.001, significantly different from control, paired t-test 
(n=5), P.O = per oral. 
 
Statistical analysis 
All data were expressed as mean + SEM; the student’s t-test was applied to determine the 
significance of the difference between the control group and the test compounds. 
 
Discussion 
 
The present study reported the synthesis of two derivatives of quinazolinone,  6-bromo-
2-methyl-4H-benzo [d] [1,3]-oxazine-4-one,(1) and 3-amino-6-bromo-2-methyl 
quinazolin-4(3H)-one(2).The compounds were investigated for their Analgesic activity. 
 
The structures of the compounds were confirmed based on their elemental and spectra 
analyses, thus IR spectrum of the compounds. Compound 1 reveals strong absorption 
band at  1730, 2871, 2718, and 3135  attributed to Umax for  C=O, CH aliphatic and NH, 
while compound 2 reveals strong absorption band at 1685, 1620 and 3350,  attributed to 
C = O,  C=N and NH. The in-vivo analgesic activity of compounds synthesized were 
determined using mouse writhing assay and the results obtained are summarized in table 
4. Compound 2 showed the highest activity at 40mg.kg compared to the other compound 
1, acetylsalicylic acid and indomethacin. . It may be that the substitution of Amino group 
at position three increase the activity. These compounds synthesized have a higher 
activity than acetylsalicyclic acid, which is a standard analgesic drug. 
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Conclusion 
 
The compounds have high Analgesic activity. Compound 2 has a higher Analgesic 
activity compared to Compound 1. 
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